Major pharmaceutical residues in wastewater treatment plants and receiving waters in Bangkok, Thailand, and associated ecological risks

Chemosphere

Volumn 91, Issue 5, 2013, Pages 697-704

  Tewari, S ^a   Jindal, R ^a   Kho, Y L ^b   Eo, S ^c   Choi, K ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Eulji University   (South Korea)

^c Seoul Research Institute of Health and Environment   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Ecological risk; Hazard quotient; Influent effluent; Pharmaceutical; Receiving water

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; CAFFEINE; CIPROFLOXACIN; DICLOFENAC; IBUPROFEN; MEFENAMIC ACID; NAPROXEN; PARACETAMOL; ROXITHROMYCIN; SULFADIMIDINE; SULFAMETHOXAZOLE; SULFATHIAZOLE; SURFACE WATER; TRIMETHOPRIM; WATER;

EFFLUENT; NOTE; RIVER; THAILAND; WASTE COMPONENT REMOVAL; WASTE WATER TREATMENT PLANT; WATER SAMPLING;

EID: 84875809662     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2012.12.042     Document Type: Article

References (39)

1. Barbara K.H., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res. 2009, 43:363-380.
2. Bendz D., Pax́eus N.A., Ginn T.R., Frank J.L. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J. Hazard Mater. 2005, 122:195-204.
3. Boxall A.B.A., Rudd M.A., Brooks B.W., Caldwell D.J., Choi K., Hickmann S., Innes E., Ostapyk K., Staveley J.P., Verslycke T., Ankley G.T., Beazley K.F., Belanger S.E., Berninger J.P., Carriquiriborde P., Coors A., Deleo P.C., Dyer S.D., Ericson J.F., Gagné F., Giesy J.P., Gouin T., Hallstrom L., Karlsson M.V., Larsson D.G., Lazorchak J.M., Mastrocco F., McLaughlin A., McMaster M.E., Meyerhoff R.D., Moore R., Parrott J.L., Snape J.R., Murray-Smith R., Servos M.R., Sibley P.K., Straub J.O., Szabo N.D., Topp E., Tetreault G.R., Trudeau V.L., Van-Der-Kraak G. Pharmaceuticals and personal care products in the environment: What are the big questions?. Environ. Health Perspect. 2012, 120:1221-1229.
4. Carballaa M., Omila F., Lemaa J.M., Llompartb M., Jaresb C.G., Isaac R. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plants. Water Res. 2004, 38:2918-2926.
5. Carlsson G., Stefan O., Joakim L. Effluent from bulk drug production is toxic to aquatic vertebrates. Environ. Toxicol. Chem. 2009, 28:2656-2662.
6. Chen M., Ohman K., Metcalfe C., Ikonomou G., Amatya P.L., Wilson J. Pharmaceuticals and endocrine disruptors in wastewater treatment effluents and in the water supply system of Calgary, Alberta. Canada. Water Qual. Res. J. Can. 2006, 41:351-364.
7. Choi K., Kim Y., Jung J., Kim M.H., Kim C.S., Kim N.H., Park J. Occurrences and ecological risks of roxithromycin, trimethoprim, and chloramphenicol in the Han River. Korea Environ. Toxicol. Chem. 2008, 27:711-719.
8. Choi K., Kim Y., Park J., Park C.K., Kim M., Kim H.S., Kim P. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River. Korea Sci. Total Environ. 2008, 405:120-128.
9. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39:4797-4807.
10. de Souza S.M., Vasconcelos E.C., Dziedzic M., de Oliveira C.M. Environmental risk assessment of antibiotics: an intensive care unit analysis. Chemosphere 2009, 77:962-967.
11. EC, 2011. Technical guidance for deriving environmental quality standards. Common implementation strategy for the water framework directive (2000/60/EC), Guidance Document No. 27, European Commission.
12. Göbel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372:361-371.
13. Gros M., Petrović M., Barceló D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal. Chem. 2009, 81:898-912.
14. Heberer T.A. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment. Toxicol. Lett. 2002, 131:5-17.
15. Hernando M.D., Mezcua M., Ferńandez-Alba A.R., Barceĺo D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
16. Jelić A., Gros M., Petrović M., Ginebreda A., Barcelo D. Occurrence and elimination of pharmaceuticals during conventional wastewater treatment. Handbook Environ. Chem. 2012, 19:1-24.
17. Jjemba P.K. Excretion and ecotoxicity of pharmaceuticals and personal care products in the environment. Ecotoxicol. Environ. Safety 2006, 63:113-130.
18. Ji K., Choi K., Lee S., Park S., Kim J.S., Jo E.H., Choi K.H., Zhang X., Giesy J.P. Effects of sulfathiazole, oxytetracycline and chlortetracycline on steroidogenesis in the human adrenocarcinoma (H295R) cell line and freshwater fish Oryziaslatipes. J. Hazard. Mater. 2010, 182:494-502.
19. Jones O.A., Voulvoulis N., Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 2002, 36:5013-5022.
20. Joss A., Elvira K., Alfredo C.A., Anke G., Christa S.M., Thomas T., Hansruedi S. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res. 2005, 39:3139-3152.
21. Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 2007, 41:1013-1021.
22. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US Streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
23. Kümmerer K. Antibiotics in the aquatic environment - a review - Part I. Chemosphere 2009, 75:417-434.
24. Li Y., Jindal R., Choi K., Kho Y.L., Bullen P.G. Pharmaceutical residues in wastewater treatment plants and surface waters in Bangkok (Thailand). J. Hazard. Toxic Radioact. Waste 2012, 16:88-91.
25. Lin A.Y.C., Yu T.H., Lin C.F. Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan. Chemosphere 2008, 74:131-141.
26. Lin A.Y.C., Yu T.H., Lateef S.K. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. J. Hazard. Mater. 2009, 167:1163-1169.
27. Lin A.Y.C., Lin C.F., Tsai Y.T., Lin H.H.H., Chen J., Wang X.H., Yu T.H. Fate of selected pharmaceuticals and personal care products after secondary wastewater treatment processes in Taiwan. Water Sci. Technol. 2010, 62:2450-2458.
28. Matamoros V., Carlos A., Hans B., Josep M.B. Removal of pharmaceuticals and personal care products (PPCPs) from urban wastewater in a pilot vertical flow constructed wetland and a sand filter. Environ. Sci. Technol. 2007, 41:8171-8177.
29. Miao X.S., Bishay F., Chen M., Metcalfe C.D. Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. Environ. Sci. Technol. 2004, 38:3533-3541.
30. Ministry of Finance Quantity of Caffeine Beverage Consumption for Thai People (Above 15Years) 2007, Thai Public Health, Department of Excise.
31. National Institute of Environmental Research Environmental Risk Assessment of Pharmaceuticals and Personal Care Products in Environment (III) 2010, Ministry of Environment, Seoul, South Korea.
32. Sim W.J., Lee J.W., Oh J.E. Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea. Environ. Pollut. 2010, 158:1938-1947.
33. Spongberg A.L., Witter J.D. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci. Total Environ. 2008, 397:148-157.
34. Stuer-Lauridsen F., Birkved M., Hansen L.P., Halling-Sørensen B., HoltenLützhøft H.C. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 2000, 40:783-793.
35. Suarez S., Carballa M., Omil F., Lema J.M. How are pharmaceutical and personal care products (PPCPs) removed from urban wastewater?. Environ. Sci. Biotechnol. 2008, 7:125-138.
36. Wang L., Ying G.G., Zhao J.L., Yang X.B., Chen F., Tao R., Liu S., Zhou L.J. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China. Sci. Total Environ. 2010, 408:3139-3147.
37. Yamamoto H., Nakamura Y., Nakamura Y., Kitani C., Imari T., Sekizawa J., Takao Y., Yamashita N., Hirai N., Oda S., Tatarazako N. Initial ecological risk assessment of eight selected human pharmaceuticals in Japan. Environ. Sci. 2007, 14:177-193.
38. Ying, G., Rai, K., Waite, T.D., 2004. Endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care product (PPCPs) in reclaimed water in Australia. Australian Water Conservation and Reuse Research Program, Australia. <>. http://www.clw.csiro.au/awcrrp/stage1files/AWCRRP_1H_Final_27Apr2004.pdf.
39. Zhao J.L., Ying G.G., Liu Y.S., Chen F., Yang J.F., Wang L., Yang X.B., Stauber J.L., Warne M.S.J. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China. Environ. Toxicol. Chem. 2010, 29:1377-1384.